Skip to main content
Premium Trial:

Request an Annual Quote

Slight Gain for BCW Index

The BCW Index rose .6 percent for the five-day trading period ended Tuesday. Though only a slight gain, it performed better than the Dow Jones Industrial Average, Nasdaq, and Nasdaq Biotech Index which fell .1 percent, .8 percent, and 1.4 percent, respectively.
 
PerkinElmer led gainers with a 3.5 percent rise, followed by Qiagen, which climbed 3.2 percent, and Bio-Rad, which closed up 3 percent. Millipore had the sharpest drop, finishing the tracking period down 1.6 percent.
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(December 12, 2006)
Last
Price
December 5, 2006)
% change
Agilent A
33.86
33.16
2.1
Applied Biosystems ABI
37.54
37.82
-0.7
Beckman BEC
59.38
60.55
-1.9
Bio-Rad BIO
84.01
81.60
3.0
Bruker BRKR
7.98
8.00
-0.2
GE GE
35.64
35.27
1.0
Invitrogen IVGN
57.67
56.90
1.4
Millipore MIL
68.79
69.89
-1.6
Molecular Devices MDCC
22.53
22.20
1.5
PerkinElmer PKI
22.26
21.50
3.5
Qiagen QGEN
14.98
14.52
3.2
Sigma SIAL
77.83
77.01
1.1
Stratagene STGN
7.52
7.55
-0.4
Thermo TMO
44.50
44.53
-0.1
Waters WAT
49.39
49.82
-0.9
BCW Index Average  
41.59
41.35
0.6

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.